What is this thing, exactly?
Octreotide is what experts call a somatostatin analog. That is just a fancy way of saying it is a man-made version of a hormone your body already produces to keep things in balance.
Think of it as a master control switch. While some peptides are designed to rev things up, this one is often used to slow things down. It has been around for over 35 years and is considered a gold-standard in its category.
How does it work (in English, please)?
This peptide is a somatostatin receptor agonist. Basically, it finds specific docking stations on your cells (specifically ones called SSTR2 and SSTR5) and plugs into them.
Once it plugs in, it tells your body to pump the brakes on a few things:
- Growth hormones: It stops the body from releasing too much growth hormone.
- Digestion signals: It suppresses the release of certain gut hormones.
- Blood flow: It reduces splanchnic blood flow, which is just the blood moving toward your internal organs.
- Insulin and Glucagon: It also puts a lid on these two hormones that usually manage your blood sugar.
Is it a new discovery?
Not at all. This is an old pro. The FDA first approved a version of it called Sandostatin all the way back in 1988.
It has also evolved over time so people do not just have to rely on one type of shot. Scientists have developed a slow-release version that goes into the muscle and even the first-ever oral version you can take as a pill.
Does it actually work?
Because it has been used for over three decades, there is a lot of data on it. In one study called CHIASMA OPTIMAL, it was compared against a placebo (which is a fake pill given to people in a study to see if the real medicine actually does anything).
In that study, the oral version of the peptide helped 58.2% of people normalize their IGF-1 levels. For the people taking the fake pill, only 19.4% saw that kind of result. Scientists use it as a benchmark or anchor when they study other growth-related peptides like sermorelin or ipamorelin.
Can you just buy it?
This is a serious medicine with a long history. New versions are still being approved, like a specific slow-release version that got the green light in Europe in 2025. This is a great one to bring up with your doctor. You can find peptide-experienced physicians in our Find a Doctor directory.
This content is sourced exclusively from TruthTides clinical reference data and does not constitute medical advice.
Referenced Peptides
This content was generated from TruthTides clinical reference data. It does not constitute medical advice. Always consult a qualified healthcare provider.